Dr. Kiehl focuses on the clinical neuroscience of major mental illnesses, with special focus on criminal psychopathy, substance abuse, and psychotic disorders (i.e. schizophrenia). He uses non-invasive techniques for measuring brain function, including event-related potentials (ERPs) and functional magnetic resonance imaging (fMRI). The goal of these studies is to elucidate and characterize the abnormal functional architecture believed to underlie these clinical disorders and to understand how psychological and/or pharmacological treatment modulates these neural processes. Ultimately, the goal of his research is to understand, diagnose, and effectively treat these clinical conditions. Sponsored Duke Center for Interdisciplinary Decision Sciences and Duke Law School.